Introduction: Although the role of circulating cell free DNA in cancer has been widely demonstrated, less is known about the role of urine cell free DNA (UcfDNA). UcfDNA can serve as a ‘liquid biopsy’ for urological and non-urological tumors, as it carries information on DNA from cells exfoliated in urine and from circulation. Areas covered: We review the studies on UcfDNA as a source of biomarkers for cancer, focusing on the new techniques and the differences between urological and non-urological tumors. We searched Pubmed for articles published between 1998 and 2016 with the following key words and phrases: ‘urine’ and ‘cell free DNA’ or ‘liquid biopsy’ or ‘cancer’. Expert commentary: Despite the few papers published on this topic, UcfDNA...
Early detection of primary bladder cancer (BCa) is vital, because stage and grade have been generall...
Targeted agents, antibody-drug conjugates, and immunotherapies are transforming the treatment of met...
Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are mirrored in t...
Urine could be a convenient source of biomarkers for different diseases and clinical applications, m...
BACKGROUND: The current methodology used to detect, diagnose, and monitor many types of cancers requ...
Copyright © 2013 Valentina Casadio et al. This is an open access article distributed under the Creat...
Over the past decade, advances in molecular biology and genomics techniques have revolutionized the ...
There is a need for informative biomarkers in localised urological cancers. At present, no method ca...
Circulating cell-free DNA has been recognized as an accurate marker for the diagnosis of prostate ca...
Urine cell-free (UCF) DNA has recently been proposed as a potential marker for early bladder cancer ...
BACKGROUND: Cell-free tumor-derived DNA (ctDNA) allows non-invasive monitoring of cancers, but its u...
Introduction: Bladder cancer detection typically requires unpleasant and costly cystoscopy, a proced...
CONTEXT: By 2020 the estimated incidence of genitourinary (GU) cancers (prostate, bladder, and kidne...
BACKGROUND:Cell-free tumor-derived DNA (ctDNA) allows non-invasive monitoring of cancers, but its ut...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...
Early detection of primary bladder cancer (BCa) is vital, because stage and grade have been generall...
Targeted agents, antibody-drug conjugates, and immunotherapies are transforming the treatment of met...
Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are mirrored in t...
Urine could be a convenient source of biomarkers for different diseases and clinical applications, m...
BACKGROUND: The current methodology used to detect, diagnose, and monitor many types of cancers requ...
Copyright © 2013 Valentina Casadio et al. This is an open access article distributed under the Creat...
Over the past decade, advances in molecular biology and genomics techniques have revolutionized the ...
There is a need for informative biomarkers in localised urological cancers. At present, no method ca...
Circulating cell-free DNA has been recognized as an accurate marker for the diagnosis of prostate ca...
Urine cell-free (UCF) DNA has recently been proposed as a potential marker for early bladder cancer ...
BACKGROUND: Cell-free tumor-derived DNA (ctDNA) allows non-invasive monitoring of cancers, but its u...
Introduction: Bladder cancer detection typically requires unpleasant and costly cystoscopy, a proced...
CONTEXT: By 2020 the estimated incidence of genitourinary (GU) cancers (prostate, bladder, and kidne...
BACKGROUND:Cell-free tumor-derived DNA (ctDNA) allows non-invasive monitoring of cancers, but its ut...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...
Early detection of primary bladder cancer (BCa) is vital, because stage and grade have been generall...
Targeted agents, antibody-drug conjugates, and immunotherapies are transforming the treatment of met...
Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are mirrored in t...